Clinical/Translational Cancer Immunotherapy

Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity
Matthew R. Schuelke, Phonphimon Wongthida, Jill Thompson, Timothy Kottke, Christopher B. Driscoll, Amanda L. Huff, Kevin G. Shim, Matt Coffey, Jose Pulido, Laura Evgin, Richard G. Vile

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 188; DOI: 10.1186/s40425-019-0673-2
Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
Madelyn Espinosa-Cotton, Samuel N. Rodman III, Kathleen A. Ross, Isaac J. Jensen, Kenley Sangodeyi-Miller, Ayana J. McLaren, Rachel A. Dahl, Katherine N. Gibson-Corley, Adam T. Koch, Yang-Xin Fu, Vladimir P. Badovinac, Douglas Laux, Balaji Narasimhan, Andrean L. Simons

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 79; DOI: 10.1186/s40425-019-0550-z
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Michael S. Hughes, Gabriel E. Molina, Steven T. Chen, Hui Zheng, Vikram Deshpande, Riley Fadden, Ryan J. Sullivan, Michael Dougan

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 292; DOI: 10.1186/s40425-019-0756-0
Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment
Hamzah Abu-Sbeih, Cynthia Nguyen Tran, Phillip S. Ge, Manoop S. Bhutani, Mazen Alasadi, Aung Naing, Amir A. Jazaeri, Yinghong Wang

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 118; DOI: 10.1186/s40425-019-0604-2
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations
Vidyalakshmi Chandramohan, Xuhui Bao, Xin Yu, Scott Parker, Charlotte McDowall, Yen-Rei Yu, Patrick Healy, Annick Desjardins, Michael D. Gunn, Matthias Gromeier, Smita K. Nair, Ira H. Pastan, Darell D. Bigner

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 142; DOI: 10.1186/s40425-019-0614-0
Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial
Hyun Cheol Chung, Hendrik-Tobias Arkenau, Jeeyun Lee, Sun Young Rha, Do-Youn Oh, Lucjan Wyrwicz, Yoon-Koo Kang, Keun-Wook Lee, Jeffrey R. Infante, Sung Sook Lee, Margaret Kemeny, Ulrich Keilholz, Bohuslav Melichar, Alain Mita, Ruth Plummer, Denis Smith, Arnold B. Gelb, Huiling Xiong, Janet Hong, Vikram Chand, Howard Safran

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 30; DOI: 10.1186/s40425-019-0508-1
Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
Valentina Bonanni, Fabrizio Antonangeli, Angela Santoni, Giovanni Bernardini

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 290; DOI: 10.1186/s40425-019-0751-5
Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis
Clint T. Allen, Sunmin Lee, Scott M. Norberg, Damian Kovalovsky, Hong Ye, Paul E. Clavijo, Siwen Hu-Lieskovan, Richard Schlegel, Jeffrey Schlom, Julius Strauss, James L. Gulley, Jane Trepel, Christian S. Hinrichs

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 119; DOI: 10.1186/s40425-019-0603-3
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, Marc Ruivard, Léa Dousset, Laurianne Grignou, Dimitri Psimaras, Johan Pluvy, Gilles Quéré, Franck Grados, Fanny Duval, Frederic Bourdain, Gwenola Maigne, Julie Perrin, Benoit Godbert, Beatris Irina Taifas, Alexandra Forestier, Anne-Laure Voisin, Patricia Martin-Romano, Capucine Baldini, Aurélien Marabelle, Christophe Massard, Jérôme Honnorat, Olivier Lambotte, Jean-Marie Michot

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 337; DOI: 10.1186/s40425-019-0821-8
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
Daan P. Hurkmans, Edwin A. Basak, Tanja van Dijk, Darlene Mercieca, Marco W. J. Schreurs, Annemarie J. M. Wijkhuijs, Sander Bins, Esther Oomen-de Hoop, Reno Debets, Markus Joerger, Arlette Odink, Astrid A. M. van der Veldt, Cor H. van der Leest, Joachim G. J. V. Aerts, Ron H. J. Mathijssen, Stijn L. W. Koolen

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 192; DOI: 10.1186/s40425-019-0669-y

Main menu

Clinical/Translational Cancer Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Clinical/Translational Cancer Immunotherapy

Pages